Khanna V, Singh K
Mol Cell Biochem. 2024; 480(3):1431-1448.
PMID: 39254870
DOI: 10.1007/s11010-024-05110-0.
Bae J, Lee H, Choi K, Lee J, Park T, Heo E
BMJ Open Respir Res. 2024; 11(1).
PMID: 39019624
PMC: 11256056.
DOI: 10.1136/bmjresp-2023-001740.
Li C, Liu S
Int J Mol Sci. 2024; 25(13).
PMID: 39000454
PMC: 11242201.
DOI: 10.3390/ijms25137347.
Farrukh S, Baig S, Hussain R, Imad R, Kulsoom O, Yousaf Rana M
Saudi J Biol Sci. 2024; 31(2):103897.
PMID: 38192544
PMC: 10772381.
DOI: 10.1016/j.sjbs.2023.103897.
Farrukh S, Baig S
Am J Clin Exp Immunol. 2023; 12(5):81-86.
PMID: 38022874
PMC: 10658162.
The Synergistic Effect of Dietary Acid Load Levels and Cigarette Smoking Status on the Risk of Chronic Obstructive Pulmonary Disease (COPD) in Healthy, Middle-Aged Korean Men.
Park J, Ha M, Song J, Kim O
Nutrients. 2023; 15(18).
PMID: 37764846
PMC: 10536353.
DOI: 10.3390/nu15184063.
Effect of PRDX6 gene polymorphism on susceptibility to chronic obstructive pulmonary disease in the Chinese Han population.
Xiong M, Guo M, Huang D, Li J, Zhou Y
Clin Respir J. 2023; 17(7):638-646.
PMID: 37329238
PMC: 10363838.
DOI: 10.1111/crj.13648.
Variants Are Associated with the Risk for COPD and NSCLC Development, Better Overall Survival of the NSCLC Patients and Increased Chemosensitivity in the H1299 Cell Line.
Baranasic J, Sutic M, Catalano C, Drpa G, Huhn S, Majhen D
Biomedicines. 2022; 10(9).
PMID: 36140341
PMC: 9496592.
DOI: 10.3390/biomedicines10092240.
An epigenome-wide study of DNA methylation profiles and lung function among American Indians in the Strong Heart Study.
Domingo-Relloso A, Riffo-Campos A, Powers M, Tellez-Plaza M, Haack K, Brown R
Clin Epigenetics. 2022; 14(1):75.
PMID: 35681244
PMC: 9185990.
DOI: 10.1186/s13148-022-01294-8.
Peripheral Blood Mononuclear Cell Gene Expression in Chronic Obstructive Pulmonary Disease: miRNA and mRNA Regulation.
Wang L, Zhao H, Raman I, Yan M, Chen Q, Li Q
J Inflamm Res. 2022; 15:2167-2180.
PMID: 35392023
PMC: 8983057.
DOI: 10.2147/JIR.S337894.
Protein interaction networks provide insight into fetal origins of chronic obstructive pulmonary disease.
Rohl A, Baek S, Kachroo P, Morrow J, Tantisira K, Silverman E
Respir Res. 2022; 23(1):69.
PMID: 35331221
PMC: 8944072.
DOI: 10.1186/s12931-022-01963-5.
A gene based approach to test genetic association based on an optimally weighted combination of multiple traits.
Zhang J, Sha Q, Liu G, Wang X
PLoS One. 2019; 14(8):e0220914.
PMID: 31398229
PMC: 6688794.
DOI: 10.1371/journal.pone.0220914.
Evaluation and Interpretation of Transcriptome Data Underlying Heterogeneous Chronic Obstructive Pulmonary Disease.
Ham S, Oh Y, Roh T
Genomics Inform. 2019; 17(1):e2.
PMID: 30929403
PMC: 6459164.
DOI: 10.5808/GI.2019.17.1.e2.
Metabolomics and transcriptomics pathway approach reveals outcome-specific perturbations in COPD.
Cruickshank-Quinn C, Jacobson S, Hughes G, Powell R, Petrache I, Kechris K
Sci Rep. 2018; 8(1):17132.
PMID: 30459441
PMC: 6244246.
DOI: 10.1038/s41598-018-35372-w.
Expansion of hedgehog disrupts mesenchymal identity and induces emphysema phenotype.
Wang C, de Mochel N, Christenson S, Cassandras M, Moon R, Brumwell A
J Clin Invest. 2018; 128(10):4343-4358.
PMID: 29999500
PMC: 6159975.
DOI: 10.1172/JCI99435.
Genetic profile and patient-reported outcomes in chronic obstructive pulmonary disease: A systematic review.
Melro H, Gomes J, Moura G, Marques A
PLoS One. 2018; 13(6):e0198920.
PMID: 29927965
PMC: 6013101.
DOI: 10.1371/journal.pone.0198920.
A candidate gene identification strategy utilizing mouse to human big-data mining: "3R-tenet" in COPD genetic research.
Vishweswaraiah S, George L, Purushothaman N, Ganguly K
Respir Res. 2018; 19(1):92.
PMID: 29871630
PMC: 5989378.
DOI: 10.1186/s12931-018-0795-y.
Cholesterol metabolism promotes B-cell positioning during immune pathogenesis of chronic obstructive pulmonary disease.
Jia J, Conlon T, Sarker R, Tasdemir D, Smirnova N, Srivastava B
EMBO Mol Med. 2018; 10(5).
PMID: 29674392
PMC: 5938615.
DOI: 10.15252/emmm.201708349.
Cross-Sectional Study of Chronic Obstructive Pulmonary Disease Prevalence Among Smokers, Ex-Smokers, and Never-Smokers in Almaty, Kazakhstan: Study Protocol.
Sharman A, Zhussupov B, Sharman D, Stambekova A, Yeraliyev S
JMIR Res Protoc. 2017; 6(7):e143.
PMID: 28743683
PMC: 5548982.
DOI: 10.2196/resprot.7422.
Anti--benzoquinone antibody level as a prospective biomarker to identify smokers at risk for COPD.
Banerjee S, Bhattacharyya P, Mitra S, Kundu S, Panda S, Chatterjee I
Int J Chron Obstruct Pulmon Dis. 2017; 12:1847-1856.
PMID: 28684907
PMC: 5485895.
DOI: 10.2147/COPD.S134455.